Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Hematology Therapeutics Market Research Reports

Titlepublishedprice

Deep Vein Thrombosis (DVT)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... lobe. A key objective of the Deep Vein Thrombosis (DVT) Report is to understand the market and pipeline status of the drugs around the Deep Vein Thrombosis (DVT) to explore the generic development opportunities, licensing opportunities and to gain co......"
01-Sep-2016$2000

Essential Thrombocythemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... obe. A key objective of the Essential Thrombocythemia Report is to understand the market and pipeline status of the drugs around the Essential Thrombocythemia to explore the generic development opportunities, licensing opportunities and to gain compe......"
01-Sep-2016$2000

Bacteremia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... ctive of the Bacteremia Report is to understand the market and pipeline status of the drugs around the Bacteremia to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline strate......"
01-Sep-2016$2000

Hemophilia A-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... jective of the Hemophilia A Report is to understand the market and pipeline status of the drugs around the Hemophilia A to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline ......"
01-Sep-2016$2000

Hemophilia B-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... jective of the Hemophilia B Report is to understand the market and pipeline status of the drugs around the Hemophilia B to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline ......"
01-Sep-2016$2000

Hereditary Angioedema (HAE)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... globe. A key objective of the Hereditary Angioedema (HAE) Report is to understand the market and pipeline status of the drugs around the Hereditary Angioedema (HAE) to explore the generic development opportunities, licensing opportunities and to gain......"
01-Sep-2016$2000

Hyperuricemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... bjective of the Hyperuricemia Report is to understand the market and pipeline status of the drugs around the Hyperuricemia to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeli......"
01-Sep-2016$2000

Hypocalcemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... jective of the Hypocalcemia Report is to understand the market and pipeline status of the drugs around the Hypocalcemia to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline ......"
01-Sep-2016$2000

Hyponatremia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... jective of the Hyponatremia Report is to understand the market and pipeline status of the drugs around the Hyponatremia to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline ......"
01-Sep-2016$2000

Hypoparathyroidism-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... key objective of the Hypoparathyroidism Report is to understand the market and pipeline status of the drugs around the Hypoparathyroidism to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on d......"
01-Sep-2016$2000